Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bode

Showing results (81-90 of 548) with videos related to

Pageof 55
Sort By:
The Journal of Nutrition|May 1, 1997
A diet rich in fat and poor in dietary fiber increases the in vitro formation of reactive oxygen species in human fecesJ G Erhardt, S S Lim, J C Bode, et al.
Der Internist|December 8, 2011
[Anticoagulation for atrial fibrillation : the future has begun]M Moser, C Bode
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 1, 1996
A deletion in the alpha subunit locks platelet integrin alpha IIb beta 3 into a high affinity stateK Peter, C Bode
Hamostaseologie|July 13, 2012
Oral anticoagulation with edoxaban. Focus on current phase III clinical developmentI Ahrens, C Bode
Der Internist|April 1, 1992
[New strategies and perspectives in thrombolytic therapy]C Bode, W Kübler
Hamostaseologie|March 29, 2018
Oral anticoagulation with edoxabanI Ahrens, C Bode
Hamostaseologie|November 3, 2009
[The role of serotonin in haemostasis]D Duerschmied, C Bode
Hamostaseologie|July 11, 2012
Vorapaxar expands antiplatelet options. Which patients may benefit from thrombin receptor antagonism?D Duerschmied, C Bode
Hamostaseologie|March 29, 2018
Vorapaxar expands antiplatelet optionsD Duerschmied, C Bode
Herz|April 20, 2011
[New developments in drug-eluting stents]M Kollum, C Bode
Pageof 55

Showing results (81-90 of 548) with videos related to

Sort By:
Pageof 55
The Journal of Nutrition|May 1, 1997
A diet rich in fat and poor in dietary fiber increases the in vitro formation of reactive oxygen species in human fecesJ G Erhardt, S S Lim, J C Bode, et al.
Der Internist|December 8, 2011
[Anticoagulation for atrial fibrillation : the future has begun]M Moser, C Bode
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 1, 1996
A deletion in the alpha subunit locks platelet integrin alpha IIb beta 3 into a high affinity stateK Peter, C Bode
Hamostaseologie|July 13, 2012
Oral anticoagulation with edoxaban. Focus on current phase III clinical developmentI Ahrens, C Bode
Der Internist|April 1, 1992
[New strategies and perspectives in thrombolytic therapy]C Bode, W Kübler
Hamostaseologie|March 29, 2018
Oral anticoagulation with edoxabanI Ahrens, C Bode
Hamostaseologie|November 3, 2009
[The role of serotonin in haemostasis]D Duerschmied, C Bode
Hamostaseologie|July 11, 2012
Vorapaxar expands antiplatelet options. Which patients may benefit from thrombin receptor antagonism?D Duerschmied, C Bode
Hamostaseologie|March 29, 2018
Vorapaxar expands antiplatelet optionsD Duerschmied, C Bode
Herz|April 20, 2011
[New developments in drug-eluting stents]M Kollum, C Bode
Pageof 55